Health Care | Pharmaceuticals and Biotechnology

SGEN 5 Dimension Analysis

Analysis Instruction of SGEN

  1. Our valuation model suggests a stable target with relatively steady profitability, indicating a relatively positive fundamental outlook.
    2. The current stock trend is bullishwith strong momentum accumulation in the short-term.
    3. The current potential for an upward price swing is higher. Considering the current swing trading score, our default strategy has a 66.67% win rate and a risk-to-reward ratio of 3.04.
    4. The institutional ownership stands at 83.81%, indicating relatively concentrated ownership. Latest quarter: 324 institutions bought, 304 institutions sold.
    5. No dividend history, not ideal for dividend-oriented buy-and-hold strategy.


Avg of Sector0.82%-8.20%-13.90%-8.93%-15.22%
S&P 500-0.23%-1.54%-1.41%9.73%14.96%

Price of SGEN